Rethinking IgA Vasculitis: A Chronic Steroid-Refractory Adult Case (ESDR 2026) - Oct 5, 2026 - Abstract #607; "Although often self-limiting, severe disease may require treatment with corticosteroids or immunosuppressants such as azathioprine and rituximab...By early 2026, the patient remained flare-free on methotrexate (15 mg weekly) and hydroxychloroquine (400 mg daily), with marked improvement in quality of life...Steroid-refractory disease underscores limitations of corticosteroids in long-term control. Sustained response to methotrexate suggests a potential role for combination immunomodulatory therapy in refractory IgAV."
Clinical • Gastrointestinal Disorder • Glomerulonephritis • IgA Nephropathy • Infectious Disease • Novel Coronavirus Disease • Renal Disease • Vasculitis
|
|
Umar Al-Haddad 1; Nabihah Hussaini 3; Mark Finn 2; Ameenah Hussaini 3; Naayema S. Hussaini 2; Priyanka Misra 2; Dushmanta Talukdar 2; Nader Ghaderi 2
|